Ophthalmology’s top five FDA approvals of 2019

Ophthalmology’s armamentarium in the United States grew in 2019 with FDA approvals in retina and glaucoma treatment, as well as an approval for the first trifocal IOL.
Here are the top five FDA approvals of the year:
 
FDA approves Alcon’s AcrySof IQ PanOptix trifocal IOL
PanOptix, which is already available in more than 70 countries, has been shown to deliver a combination of near, intermediate and distance vision while significantly reducing the need for glasses after surgery. Read more.
 
FDA approves Rocklatan for open-angle glaucoma, ocular hypertension
A fixed-dose

Full Story →